Clinical Trials Directory

Trials / Completed

CompletedNCT03662113

Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy

Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy: a Prospective Randomized Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Children's Hospital of Fudan University · Academic / Other
Sex
All
Age
3 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Video capsule endoscopy (VCE) has become an established technique to investigate the presence of small bowel pathology. But the limited battery life of capsules can lead to incomplete small bowel visualization. There is a rationale to use prokinetic agents prior to VCE reduce the chances of an incomplete small bowel examination via decrease gastric transit time (GTT). Investigators are aimed to prospectively compare the completion rate of VCE in pediatric patients receiving prokinetic with those receiving no prokinetic.

Detailed description

Eligible children were randomly divided into two groups: domperidone prior to VCE and water prior to VCE. The primary outcome measure was the completion rate. Secondary outcome measures included the GTT and SBTT.

Conditions

Interventions

TypeNameDescription
DRUGDomperidone5ml Domperidone prior to VCE
DIETARY_SUPPLEMENTwater5ml water prior to VCE

Timeline

Start date
2017-11-01
Primary completion
2018-11-01
Completion
2018-11-01
First posted
2018-09-07
Last updated
2018-12-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03662113. Inclusion in this directory is not an endorsement.

Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy (NCT03662113) · Clinical Trials Directory